PINNA, Gerard Aime
 Distribuzione geografica
Continente #
NA - Nord America 6.235
AS - Asia 4.193
EU - Europa 3.873
SA - Sud America 3.385
AF - Africa 197
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 17.931
Nazione #
US - Stati Uniti d'America 6.102
BR - Brasile 3.067
CN - Cina 1.742
UA - Ucraina 1.707
SG - Singapore 1.347
DE - Germania 619
HK - Hong Kong 452
SE - Svezia 398
IT - Italia 350
FI - Finlandia 275
TR - Turchia 199
GB - Regno Unito 162
AR - Argentina 106
RU - Federazione Russa 91
FR - Francia 81
IQ - Iraq 64
BD - Bangladesh 60
MA - Marocco 56
EC - Ecuador 52
VE - Venezuela 44
ZA - Sudafrica 44
BE - Belgio 42
IN - India 39
MX - Messico 39
UZ - Uzbekistan 39
CA - Canada 36
CO - Colombia 33
PK - Pakistan 33
TN - Tunisia 26
AU - Australia 24
CZ - Repubblica Ceca 24
PY - Paraguay 23
CL - Cile 22
IR - Iran 21
KE - Kenya 20
JO - Giordania 19
KR - Corea 19
AZ - Azerbaigian 18
PE - Perù 18
EU - Europa 17
NP - Nepal 16
IE - Irlanda 15
AE - Emirati Arabi Uniti 14
DO - Repubblica Dominicana 14
AL - Albania 13
EG - Egitto 13
RO - Romania 13
DZ - Algeria 12
JP - Giappone 12
OM - Oman 12
UY - Uruguay 12
KZ - Kazakistan 11
NL - Olanda 11
LB - Libano 9
SN - Senegal 9
GE - Georgia 8
JM - Giamaica 8
PA - Panama 8
BG - Bulgaria 7
BO - Bolivia 7
CR - Costa Rica 7
HN - Honduras 7
MD - Moldavia 7
PS - Palestinian Territory 7
RS - Serbia 7
AM - Armenia 6
AT - Austria 6
ID - Indonesia 6
IL - Israele 6
PL - Polonia 6
VG - Isole Vergini Britanniche 6
BH - Bahrain 5
ES - Italia 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
CI - Costa d'Avorio 4
ML - Mali 4
PH - Filippine 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
HU - Ungheria 3
KH - Cambogia 3
MN - Mongolia 3
NG - Nigeria 3
PT - Portogallo 3
AO - Angola 2
BN - Brunei Darussalam 2
DK - Danimarca 2
GT - Guatemala 2
IS - Islanda 2
LT - Lituania 2
MC - Monaco 2
NI - Nicaragua 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TG - Togo 2
TH - Thailandia 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 17.909
Città #
Chandler 1.419
Jacksonville 1.022
Singapore 804
Princeton 546
Dearborn 503
Nanjing 489
Hong Kong 445
Wilmington 248
Ann Arbor 211
São Paulo 188
Shanghai 162
Nanchang 152
Beijing 147
New York 131
Izmir 117
Sassari 114
Shenyang 113
Woodbridge 111
Boardman 109
Hebei 105
Changsha 95
Rio de Janeiro 86
Belo Horizonte 81
Jiaxing 69
Andover 67
Kunming 62
Ashburn 61
Tianjin 58
Brasília 55
Santa Clara 49
Jinan 42
Brussels 41
San Mateo 41
Curitiba 40
Ningbo 40
Porto Alegre 40
Tashkent 39
San Francisco 33
Baghdad 31
Helsinki 30
Hangzhou 29
Norwalk 29
Fortaleza 28
Toronto 28
Zhengzhou 28
Guarulhos 27
Leawood 27
Munich 27
Ribeirão Preto 27
Sorocaba 27
Guangzhou 26
Istanbul 26
Mountain View 25
Santo André 25
Campinas 24
Guayaquil 23
Salvador 23
Monmouth Junction 22
Taizhou 22
Recife 21
São José do Rio Preto 21
Augusta 20
Campo Grande 20
Dallas 20
Goiânia 20
Osasco 20
Caxias do Sul 19
Contagem 19
Lanzhou 19
São José dos Campos 19
Amman 18
Baku 18
Casablanca 18
Dhaka 18
Houston 18
Nairobi 18
Rome 18
Seoul 18
Tunis 17
Uberlândia 17
Bogotá 16
Brno 16
Quito 16
Ardabil 15
Auburn Hills 15
Lima 15
Los Angeles 15
Volta Redonda 15
Dublin 14
Itaquaquecetuba 14
Juiz de Fora 14
London 14
Londrina 14
Manaus 14
Rio Grande 14
Betim 13
Caraguatatuba 13
Duque de Caxias 13
Franca 13
Nova Iguaçu 13
Totale 9.371
Nome #
1,10-Phenanthrolines derived from naturally occurring ketones as ligands for asymmetric catalysis: enantioselective palladium catalyzed allylic substitution 144
1,10-phenanthrolines derived from natural occurring ketones as ligands for asymmetric catalysis: enantioselective palladium catalyzed allylic substitution 137
A hydrophilic interaction ultraperformance liquid chromatography (HILIC-UPLC) method for genomic DNA methylation assessment by UV detection 115
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 112
A new selective pre-column ninhydrin-based derivatization for a RP-HPLC determination of plasma asymmetric dimethyl-L-arginine (ADMA) by fluorescence detection 109
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 107
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 105
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 100
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 98
A new general regression-based approach for method comparison studies 96
Addition reactions of acetylenic esters to 6,7-dihydrobenzo[b]furan-4-(5H)-one, 6,7-dihydroindol-4(5H)-one, 5,6-dihydrobenzo[b]furan-7(6H)-one and 5,6-dihydroindol-7(6H)-one ketoximes. Formation of reduced furo[g]- and pyrrole[g]indoles 96
Pyridazine N-oxides. I. Synthesis and in vitro antimicrobial evaluation of 3-methyl-4-aryl-6-R-pyridazine N-oxides 95
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 95
Composti farmaceutici 95
Approcci terapeutici contro il cancro. Tradizione e innovazione. 95
An easy route to optically active 1-substituted-1-pyridyl-methylamines by diastereoselective reduction of enantiopure N-tert-butanesulfinyl ketimines 94
Addiction reaction of acetylenic esters upon 6-substituted-a-tetralon ketoximes and conversion of the adducts into 4,5-dihydro-1H-benz[g]indoles 94
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 93
Chiral 8-Amino Substituted 2-Phenyl-5,6,7,8-tetrahydro-6,6-dimethylmathanoquinolines as Chiral Ligands for Enantioselective Catalysis: Palladium Catalysed Allylic Substitution and Addition of Diethylzinc to Benzaldehyde 93
Addiction reaction of acetylenic esters upon 6-substituted-a-tetralon ketoximes and conversion of the adducts into 4,5-dihydro-1H-benz[g]indoles 92
D-Penicillamine Interferes With S-Homocysteinylation and S-Cysteinylation of LDL Apolipoprotein B 91
Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides 90
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 90
Pyridazine N-oxides. II. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides 90
CAPITOLO 41. Antielmintici 90
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 89
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 89
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 89
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 89
Enantioselective Addition of Diethylzinc to Benzaldehydes in the Presence of Sulfur-Containing Pyridine Ligands 88
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 88
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 88
The organic chemistry of drug design and drug action 86
Chiral 8-amino substituted 2-phenyl-5,6,7,8-tetrahydro-6,6-dimethylmethanoquinolines as chiral ligands for enantioselective catalysis: Palladium catalysed allylic substitution and addition of diethylzinc to benzaldehyde 86
Pharmaceutical Compounds 85
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 85
A diethylpyrocarbonate-based derivatization method for the LC-MS/MS measurement of plasma arginine and its chemically related metabolites and analogs 85
Development of an LC-Tandem Mass Spectrometry Method for the Quantitative Analysis of Hercynine in Human Whole Blood 85
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 85
Novel pyrazole derivatives as neutral CB1 antagonists with significant activity towards food intake 84
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 84
Application of an unusual ninhydrin-based reaction for the indirect chiral resolution of D,L-penicillamine 84
Microemulsions 83
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 83
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 83
Pharmaceutical Compounds 83
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 82
Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones 82
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 82
CONFORMATIONALLY RESTRICTED CONGENERS OF HYPOTENSIVE AND PLATELET-AGGREGATION INHIBITORS - 6-ARYL-5-METHYL-4,5-DIHYDRO-3(2H)-PYRIDAZINONES DERIVED FROM 5H-INDENO[1,2-C]PYRIDAZINE 82
3,6-Diazabicyclo[3.1.1]heptane derivatives with analgesic activity 81
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 81
SINTESI E ATTIVITA' FARMACOLOGIADI 6-METIL-5-FENIL-4,5-DIIDRO-3-(2H)PIRIDAZINON-4-CARBOSSAMIDI 81
RIGID CONGENERS OF ARYLPYRIDAZINONES .4. SYNTHESIS AND ACTIVITY OF DERIVATIVES OF THE NEW HETEROCYCLIC SYSTEM 9H-INDENO[2,1-C]PYRIDAZINE 81
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 80
Synthesis of 1-methyl-2,3-dimethyl-N(isopropyl)carbamates-4,5-dihydro-7-R'- 8-R-1H-benzo[g]indoles and evaluation of in vitro anticancer activity 79
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 79
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 79
ANTIHYPERTENSIVE AND ANTITHROMBOTIC ACTIVITIES OF 6-(SUBSTITUTED PHENYL)-5-HYDROXYMETHYL-4,5-DIHYDRO-3(2H)PYRIDAZINONES 79
Ex vivo impact of functionalized carbon nanotubes on human immune cells 79
NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile 78
Pyridazine N-oxides .2. Synthesis and in vitro antimicrobial evaluation of 3-chloro-4-carbamoyl-5-aryl-6-methyl-pyridazine N-oxides 78
Improved rapid assay of plasma uric acid by short-end injection capillary zone electrophoresis 78
Oxadiazoles having anti proliferative activity 77
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 77
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 4,4A-DIHYDRO-5H-[1]BENZOPYRANO[4,3-C]PYRIDAZIN-3(2H)-ONES BIOISOSTERS OF ANTIHYPERTENSIVE AND ANTITHROMBOTIC BENZO[H]CINNOLINONES 77
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 77
Synthesis and in vitro anticancer activity evaluation of biscarbamic esters of 2,3-bis(hydroxymethyl)-1-methyl-7- and 7,8-substituted- benzo[g]indoles 76
Tricyclic pyridazines: a versatile substrate for pharmacologically active compounds 76
Tricyclic pyrazole derivatives and microemulsions thereof as CB1 and/or CB2 inhibitors. 76
A facile and general synthesis of 2,5,6-trisubstituted-6,7-dihydro-1,3,4-oxadiazepines 75
Synthesis and pharmacological evaluation of 4a-methyl-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-ones 75
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 75
“Enantioselective Palladium Catalyzed Allylic Substitution with 2,2'-Bipyridine Ligands 75
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 75
Novel diazabicycloalkane delta opioid agonists 75
Tricyclic pyrazoles. An Efficient approach to cannabinoid analogues with a tricyclic framework incorporating the pyrrole and pyrazole moieties 75
Chiral 2-(2-phenylthiophenyl)-5,6,7,8-tetrahydroquinolines: new N-S ligands for asymmetric catalysis - Palladium-catalyzed allylic alkylation and copper-catalyzed cyclopropanation reactions 74
Bisbenzo[g]indoli: sintesi e attività citostatica 74
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 74
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 74
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 74
Sintesi e attività microbiologica in vitro di 3-cloro-4-carbamoil-5-aril-6-metil-piridazine N-ossidi 74
Investigation on the synthesis of α-methylarylacetic acid by direct α-methylation of arylacetonitriles 74
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 74
ADDITION-REACTIONS OF ACETYLENIC ESTERS UPON 1-(2-THIENYL)-PYRROLES AND 1-(3-THIENYL)-ETHANONE OXIMES AND UPON 6,7-DIHYDRO-BENZO[B]THIOPHEN-4(5H)-ONE AND 5,6-DIHYDROBENZO[B]-THIOPHENE-7(4H)-ONE OXIMES - FORMATION OF 2-(THIENYL)-PYRROLES AND 4,5-DIHYDRO-1H-THIENO[G]INDOLES 73
Synthesis and application of new iminopyridine ligands toenantioselective copper(II)-catalyzed Henry reaction 73
Steric versus electronic effect of the ligand in the enantioselective palladium-catalyzed allylic alkylation with chiral oxazolinylpyridines 73
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 73
Chiral P,N-ligands with pyridine-nitrogen and phosphorus donor atoms. Syntheses and applications in asymmetric catalysis 73
Diuretic agents related to indapamide. III--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-1,2,3,4-tetrahydroquinolines and 1,2,3,4-tetrahydroisoquinolines. 73
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 73
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 72
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 72
Synthesis of 4-(diphenylphosphanylmethyl)- and 4-(phenylthiomethyl)-1,4-methano-11,11-dimethyl-1,2,3,4-tetrahydroacridine: new N-P and N-S camphor-derived chiral ligands for asymmetric catalysis 72
Pharmaceutical compounds 72
Oxadiazoles having antiproliferative activity 72
Plasma L-Ergothioneina measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection 71
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 71
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 71
Totale 8.415
Categoria #
all - tutte 83.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020376 0 0 0 0 0 0 0 0 0 91 278 7
2020/20212.174 268 6 341 18 260 89 276 23 318 315 213 47
2021/20221.330 200 19 22 9 8 9 81 111 120 71 124 556
2022/20232.715 307 132 73 457 275 469 10 325 467 16 114 70
2023/2024709 130 43 28 19 79 124 5 58 3 23 75 122
2024/20256.491 48 51 409 109 295 212 450 1.289 2.805 823 0 0
Totale 18.107